日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lifestyle intervention to prevent postpartum type 2 diabetes in Asian women with recent gestational diabetes and normal post-pregnancy glucose tolerance: study protocol for a randomized controlled trial with a targeted postpartum lifestyle programme

针对近期患有妊娠糖尿病且产后糖耐量正常的亚洲女性,开展生活方式干预以预防产后2型糖尿病:一项随机对照试验的研究方案,该试验采用有针对性的产后生活方式干预方案

Quah, Phaik Ling; Song, He; Han, Wee Meng; Lim, Ethel Jie Kai; Bakar, Muhammad Alif Abu; Fadzully, Fadzlynn; Tan, Lay Kok; Suzanna, Sulaiman; Eriksson, Johan Gunnar; Chan, Shiao-Yng; Finkelstein, Eric Andrew; Tan, Kok Hian

Decoding the selective chemical modulation of CYP3A4

解码CYP3A4的选择性化学调节

Jingheng Wang #,Stanley Nithianantham #,Sergio C Chai #,Young-Hwan Jung #,Lei Yang,Han Wee Ong,Yong Li,Yifan Zhang,Darcie J Miller,Taosheng Chen

Management of Coronary Artery Disease in Patients With Severe Aortic Stenosis

重度主动脉瓣狭窄患者的冠状动脉疾病管理

Kim, Ju Hyeon; Kang, Do-Yoon; Ahn, Jung-Min; Seo, Kyeong-Won; Lee, Seung Han; Wee, Seong-Bong; An, Soo Yeon; Park, Hansu; Park, Duk-Woo; Park, Seung-Jung

More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5- a]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus Replication

不仅仅是酰胺生物电子等排体:发现含 1,2,4-三唑的吡唑并[1,5- a]嘧啶宿主 CSNK2 抑制剂用于对抗 β-冠状病毒复制

Han Wee Ong, Xuan Yang, Jeffery L Smith, Rebekah J Dickmander, Jason W Brown, Tammy M Havener, Sharon Taft-Benz, Stefanie Howell, Marcia K Sanders, Jacob L Capener, Rafael M Couñago, Edcon Chang, Andreas Krämer, Nathaniel J Moorman, Mark Heise, Alison D Axtman, David H Drewry, Timothy M Willson

Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2

通过战略性氟化获得强效、选择性、代谢稳定且口服生物可利用的 CSNK2 抑制剂

Han Wee Ong, Xuan Yang, Jeffery L Smith, Sharon Taft-Benz, Stefanie Howell, Rebekah J Dickmander, Tammy M Havener, Marcia K Sanders, Jason W Brown, Rafael M Couñago, Edcon Chang, Andreas Krämer, Nathaniel J Moorman, Mark Heise, Alison D Axtman, David H Drewry, Timothy M Willson

Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology

发现并表征丝氨酸-苏氨酸激酶细胞周期蛋白依赖性激酶样 5 (CDKL5) 的特定抑制剂,证明其在海马 CA1 生理学中发挥作用

Anna Castano #, Margaux Silvestre #, Carrow I Wells, Jennifer L Sanderson, Carla A Ferrer, Han Wee Ong, Yi Lang, William Richardson, Josie A Silvaroli, Frances M Bashore, Jeffery L Smith, Isabelle M Genereux, Kelvin Dempster, David H Drewry, Navlot S Pabla, Alex N Bullock, Tim A Benke, Sila K Ultani

Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore

发现具有 II 型抑制剂药效团的强效恶性疟原虫蛋白激酶 6 (PfPK6) 抑制剂

Han Wee Ong, Anna Truong, Frank Kwarcinski, Chandi de Silva, Krisha Avalani, Tammy M Havener, Michael Chirgwin, Kareem A Galal, Caleb Willis, Andreas Krämer, Shubin Liu, Stefan Knapp, Emily R Derbyshire, Reena Zutshi, David H Drewry

How many kinases are druggable? A review of our current understanding

有多少种激酶是可成药的?对我们目前理解的回顾

Anderson, Brian; Rosston, Peter; Ong, Han Wee; Hossain, Mohammad Anwar; Davis-Gilbert, Zachary W; Drewry, David H

Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective

发现具有神经保护作用的强效选择性 CDKL5/GSK3 化学探针

Han Wee Ong, Yi Liang, William Richardson, Emily R Lowry, Carrow I Wells, Xiangrong Chen, Margaux Silvestre, Kelvin Dempster, Josie A Silvaroli, Jeffery L Smith, Hynek Wichterle, Navjot S Pabla, Sila K Ultanir, Alex N Bullock, David H Drewry, Alison D Axtman

Characterization of 2,4-Dianilinopyrimidines Against Five P. falciparum Kinases PfARK1, PfARK3, PfNEK3, PfPK9, and PfPKB

2,4-二苯胺基嘧啶类化合物对五种恶性疟原虫激酶 PfARK1、PfARK3、PfNEK3、PfPK9 和 PfPKB 的活性表征

Ong, Han Wee; de Silva, Chandi; Avalani, Krisha; Kwarcinski, Frank; Mansfield, Christopher R; Chirgwin, Michael; Truong, Anna; Derbyshire, Emily R; Zutshi, Reena; Drewry, David H